Abstract
Papillary carcinoma of the breast represents ~0.5% of all newly diagnosed cases of breast cancer. The prevalence of both invasive and in situ papillary carcinoma seems to be greater in older postmenopausal women and, in relative terms, in males. Histologic features of the tumor include cellular proliferations surrounding fibrovascular cores, with or without invasion. In this review, characteristics of both in situ and invasive disease are outlined. Immunohistochemical analyses of papillary carcinoma suggest the utility of markers such as smooth muscle myosin heavy chain, calponin, p63, and high molecular weight keratins, which can characterize the myoepithelial cell layer. With respect to radiographic evaluation of papillary carcinoma, ultrasonography is the most extensively studied imaging modality, though magnetic resonance mammography has potential utility. Available data suggest improved outcome for papillary carcinoma as compared to invasive ductal carcinoma. Treatment-related information for patients with papillary carcinoma is limited, and patterns noted in available series suggest a variable approach to this disease. The scarcity of information underscores the need for further treatment- and outcome-related studies in papillary carcinoma of the breast.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA A Cancer J Clin 59(4):225–249
Louwman MWJ, Vriezen M, van Beek MW, Nolthenius-Puylaert MC, van der Sangen MJ, Roumen RM et al (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121(1):127–135
McCulloch GL, Evans AJ, Yeoman L (1997) Radiological features of papillary carcinoma of the breast. Clin Radiol 73:865–868
Grabowski J, Salzstein SL, Sadler GR, Blair S (2008) Intracystic papillary carcinoma. Cancer 113(5):916–920
Mulligan AM, O’Malley FP (2007) Papillary lesions of the breast: a review. Adv Anat Pathol 14(2):108–119
Collins LC, Schnitt SJ (2008) Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 52(1):20–29
Ueng SH, Mezzetti T, Tavassoli FA (2009) Papillary neoplasms of the breast: a review. Arch Pathol Lab Med 133(6):893–907
Page DL, Salhany KE, Jensen RA, Dupont WD (1996) Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78(2):258–266
Hill CB, Yeh IT (2005) Myoepithelial cell staining patterns of papillary breast lesions. Am J Clin Pathol 123(1):36–44
Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ (2006) Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 30(8):1002–1007
Esposito NN, Dabbs DJ, Bhargava R (2009) Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases. Am J Clin Pathol 131(2):228–242
Maluf HM, Koerner FC (1995) Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 19(11):1237–1244
Nassar H, Qureshi H, Volkanadsay N, Visscher D (2006) Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30(4):501–507
Moritani S, Ichihara S, Kushima R, Okabe H, Bamba M, Kobayashi T et al (2007) Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia. Virchows Arch 450(5):539–547
Nicolas MM, Wu Y, Middleton LP, Gilcrease MZ (2007) Loss of myoepithelium is variable in solid papillary carcinoma of the breast. Histopathology 51(5):657–665
Fisher ER, Palekar AS, Redmond C (1980) Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) VI. Invasive papillary cancer. Am J Clin Pathol 73:313–322
Walsh MM, Bleiweiss IJ (2001) Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 32(6):583–589
Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D (2001) Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 14(9):836–841
Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G (2004) Invasive micropapillary carcinoma of the breast. Am J Clin Pathol 121(6):857–866
Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid M (2006) Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Histopathology 48(6):683–691
Grin A, O’Malley FP, Mulligan AM (2009) Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. Am J Surg Pathol 33(11):1615–1623
Rabban JT, Koerner FC, Lerwill MF (2006) Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol 37(7):787–793
Tan PH, Aw MY, Yip G, Bay BH, Sii LH, Murugaya S et al (2005) Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 29(5):625–632
Cristofano CD, Mrad K, Zavaglia K, Bertacca G, Aretini P, Cipollini G et al (2005) Papillary lesions of the breast: a molecular progression? Breast Cancer Res Treat 90(1):71–76
Tsuda H, Takarabe T, Inazawa J, Hirohashi S (1997) Detection of numerical alterations of chromosomes 3, 7, 17 and X in low-grade intracystic papillary tumors of the breast by multi-color fluorescence in situ hybridization. Breast Cancer 4(4):247–252
Ganesan S, Karthik G, Joshi M, Damodaran V (2006) Ultrasound spectrum in intraductal papillary neoplasms of breast. Br J Radiol 79(946):843–849
Kim TH, Kang DK, Kim SY, Lee EJ, Jung YS, Yim H (2008) Sonographic differentiation of benign and malignant papillary lesions of the breast. J Ultrasound Med 27(1):75–82
Lam WWM, Chu WCW, Tang APY, Tse G, Ma TKF (2006) Role of radiologic features in the management of papillary lesions of the breast. Am J Roentgenol 186(5):1322–1327
Linda A, Londero V, Mazzarella F, Zuiani C, Bazzocchi M (2007) Rare breast neoplasms: is there any peculiar feature on magnetic resonance mammography? Radiol Med 112(6):850–862
Bernik SF, Troob S, Ying BL, Simpson SA, Axelrod DM, Siegel B et al (2009) Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up. Am J Surg 197(4):473–478
Anderson W, Devesa SS (2005) In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer 104(8):1733–1741
Burga A, Fadare O, Lininger R, Tavassoli F (2006) Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 449(5):507–512
Anan H, Okazaki M, Fujimitsu R, Hamada Y, Sakata N, Nanbu M (2000) Intracystic papillary carcinoma in the male breast. A case report. Acta Radiol 41(3):227–229
Bhatia A, Saikia UN, Kumar Y (2008) Rare coexistence of invasive papillary carcinoma with infiltrating ductal carcinoma in male breast: report of a case. Int J Surg Pathol 16(3):311–313
Blaumeiser B, Tjalma W, Verslegers I et al (2002) Invasive papillary carcinoma of the male breast. Eur Radiol 12(9):2207–2210
Dragoumis D, Tsiftsoglou A (2008) Intracystic papillary carcinoma associated with ductal carcinoma in situ in a male breast. J Postgrad Med 54(1):39–40
Imoto S, Hasebe T (1998) Intracystic papillary carcinoma of the breast in male: case report and review of the Japanese literature. Jpn J Clin Oncol 28(8):517–520
Pacelli A, Bock BJ, Jensen EA, Heerden JA, Reynolds C (2002) Intracystic papillary carcinoma of the breast in a male patient diagnosed by ultrasound-guided core biopsy: a case report. Breast J 8(6):387–390
Takayuki K, Takashi F, Eriko I, Miyuki T, Sadako A-T, Tadashi H (2005) Intracystic papillary carcinoma of the breast in a male patient diagnosed by core needle biopsy: a case report. Breast 14(4):322–324
Tochika N, Takano A, Yoshimoto T, Tanaka J, Sugimoto T, Kobayashi M et al (2001) Intracystic carcinoma of the male breast: report of a case. Surg Today 31(9):806–809
Zeppa P, Mascolo M, Zabatta A, Finelli L, Vetrani A, Palombini L (2003) Aggressive papillary male breast carcinoma on fine-needle cytology sample. Diagn Cytopathol 29(6):360–363
Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM et al (2002) Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 184(4):364–368
Fayanju OM, Ritter J, Gillanders WE, Eberlein TJ, Dietz JR, Aft R et al (2007) Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg 194(4):497–500
Baehner FL, Watson D, Ballard JT, Palmer G, Shak S (2008) Gene expression by standardized quantitative RT-PCR in the special histologic subtypes of estrogen receptor positive invasive breast cancer. Breast Cancer Res Treat (Abstr 3028)
Welsch C, Brown C, Goodrich-Smith M, Van J, Denenberg B, Anderson T et al (1979) Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion. J Natl Cancer Inst 63:1121–1124
Acknowledgment
Dr. Pals’s efforts are supported by CBCRP 15IB-0140 (California Breast Cancer Research Program Junior IDEA Award) and NIH K12 2K12CA001727-16A1.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pal, S.K., Lau, S.K., Kruper, L. et al. Papillary carcinoma of the breast: an overview. Breast Cancer Res Treat 122, 637–645 (2010). https://doi.org/10.1007/s10549-010-0961-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-0961-5